Suscribirse

Harnessing implementation science to optimize harm prevention in critically ill children: A pilot study of bedside nurse CLABSI bundle performance in the pediatric intensive care unit - 25/02/21

Doi : 10.1016/j.ajic.2020.08.019 
Charlotte Z. Woods-Hill, MD, MSHP a, b, c, , Kelly Papili, MSN, RN, ACCN-P a, Eileen Nelson, BSN, RN a, Kathryn Lipinski, BSN, RN, CCRN a, Judy Shea, PhD b, d, Rinad Beidas, PhD d, e, f, g, Meghan Lane-Fall, MD, MSHP b, c, f, h
a Division of Critical Care Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 
b The Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA 
c Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 
d Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 
e Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 
f Penn Implementation Science Center at the Leonard Davis Institute of Health Economics (PISCE@LDI), Philadelphia, PA 
g Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 
h Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 

Address correspondence to Charlotte Z Woods-Hill, MD, MSHP, Division of Critical Care Medicine, The Children's Hospital of Philadelphia, 3401 Civic Center Blvd, Wood Building, 6th Floor, Suite 6026A, Philadelphia, PA 19104.Division of Critical Care MedicineThe Children's Hospital of Philadelphia3401 Civic Center Blvd, Wood Building, 6th Floor, Suite 6026APhiladelphiaPA19104

Highlights

Central-line associated bloodstream infections (CLABSIs) have serious negative consequences.
Compliance by nurses with a bundle to prevent CLABSI is suboptimal.
Implementation and behavioral science offer new insights into why compliance is challenging.
Strategies that facilitate opportunity and optimize motivation may improve bundle compliance.

El texto completo de este artículo está disponible en PDF.

Resumen

Objective

Central-line associated bloodstream infection (CLABSI) is associated with increased mortality, morbidity, and cost in hospitalized children. An evidence-based bundle of care can decrease CLABSI, but bundle compliance is imperfect. We explored factors impacting bundle performance in the pediatric intensive care unit (PICU) by bedside nurses.

Methods

Single-center cross-sectional electronic survey of PICU bedside nurses in an academic tertiary care center; using the COM-B (capability, opportunity, motivation) and TDF (theoretical domains framework) behavioral models to explore CLABSI bundle performance and identify barriers to compliance.

Results

We analyzed 160 completed surveys from 226 nurses (71% response rate). CLABSI knowledge was strong (capability). However, challenges related to opportunity were identified: 71% reported that patient care requirements impact bundle completion; 32% described the bundle as stressful; and CLABSI was viewed as the most difficult of all bundles. Seventy-five percent reported being highly impacted by physician attitude toward the CLABSI bundle (motivation).

Conclusions

PICU nurses are knowledgeable and motivated to prevent CLABSI, but face challenges from competing clinical tasks, limited resources, and complex family interactions. Physician engagement was specifically noted to impact nurse motivation to complete the bundle. Interventions that address these challenges may improve bundle performance and prevent CLABSI in critically ill children.

El texto completo de este artículo está disponible en PDF.

Key Words : Central-line associated bloodstream infection, Infection prevention, Bacteremia, Hospital-acquired infection, Behavioral science


Esquema


 Funding: There were no direct sources of funding for this work. Dr Woods-Hill received support from a National Institute of Health Ruth L. Kirschstein National Research Service Award (T32HL098054-55) and receives support from The Agency for Healthcare Research and Quality (1R18HS025642). Dr Lane-Fall receives support from the Robert Wood Johnson Foundation, the NIA, and NHLBI.
 Conflicts of interest: Dr Beidas receives royalties from Oxford University Press and has provided consultation to Merck and Camden Coalition of Healthcare Providers. The authors have no other financial relationships or conflicts of interest to disclose.


© 2020  Association for Professionals in Infection Control and Epidemiology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 49 - N° 3

P. 345-351 - mars 2021 Regresar al número
Artículo precedente Artículo precedente
  • Additional medical costs associated with ventilator-associated pneumonia in an intensive care unit in Japan
  • Taikan Nanao, Hideo Nishizawa, Junichi Fujimoto, Toshio Ogawa
| Artículo siguiente Artículo siguiente
  • Impact of the blue-carba rapid test for carbapenemase detection on turnaround time for an early therapy against Pseudomonas aeruginosa
  • Rick Shandler Rodrigues da Cunha, Eliana Carniel, Gabriel Azambuja Narvaez, Cícero Gomes Dias, Leandro Reus Rodrigues Perez

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.